Drug
M0324
M0324: highest development phase Phase 1, developed by Merck KGaA. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merck KGaA
Trials
| Drug | Phase | Indication |
|---|---|---|
| M0324 NCT07166601 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow M0324 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.